7548
C. C. Silveira et al. / Tetrahedron Letters 47 (2006) 7545–7549
added dichloromethane solutions of BF3ÆEt2O (1.5 equiv)
Acknowledgments
and PhSH (0.1–2 equiv). The reaction was left to proceed
under the conditions (time and temperature) shown in
Table 1. Then, the reaction was quenched with brine
(5 mL) and the products were extracted with EtOAc
(4 · 20 mL); the combined extracts were washed once with
brine (5 mL), dried (Na2SO4), concentrated under reduced
pressure, and the residue was submitted to column
chromatography.
The authors acknowledge the financial support provided
´
by CAPES, MCT/CNPq and Fundacion Antorchas.
T.S.K. also thanks CONICET and ANPCyT (Project
06-12532).
References and notes
10. Spectral data for selected compounds: 6,7-Dimethoxy-2-
(toluene-4-sulfonyl)-1-p-tolyl-1,2,3,4-tetrahydroisoquino-
line. Mp: 121–122 ꢁC; IR (KBr, cmÀ1): 2934, 2835, 1611,
1. (a) Whaley, W. M.; Govindachari, T. R. The Pictet–
Spengler Synthesis of Tetrahydroisoquinolines and
Related Compounds. In Organic Reactions; Adams, R.,
Ed.; John Wiley and Sons: New York, USA, 1951; Vol. 6,
p 151; (b) Kametani, T. In The Total Synthesis of Natural
Products; ApSimon, J., Ed.; Wiley: New York, USA,
1977; Vol. 3, pp 1–272; (c) Kutney, J. P. In The Total
Synthesis of Natural Products; ApSimon, J., Ed.; Wiley:
New York, USA, 1977; Vol. 3, pp 273–288; (d) Jones, G.
In Comprehensive Heterocyclic Chemistry; Katritzky, A.
R., Rees, C. W., Eds.; Pergamon: Oxford, UK, 1984; Vol.
2, pp 438–440; (e) Cox, E. D.; Cook, J. M. Chem. Rev.
1995, 95, 1797; (f) Kaufman, T. S. Synthesis of Optically-
Active Isoquinoline and Indole Alkaloids Employing the
Pictet–Spengler Condensation with Removable Chiral
Auxiliaries Bound to Nitrogen. In New Methods for the
Asymmetric Synthesis of Nitrogen Heterocycles; Vicario, J.
L., Ed.; Research SignPost: Trivandrum, 2005; pp 99–147,
Chapter 4.
1
1519, 1464, 1337, 1247, 1159, 1018, 857, 731, and 658; H
NMR (200 MHz, CDCl3, d): 2.30 (s, 3H), 2.32 (s, 3H),
2.41–2.73 (m, 2H), 3.14–3.29 (m, 1H), 3.74 (s, 3H), 3.75–
3.80 (m, 1H), 3.81 (s, 3H), 6.12 (s, 1H), 6.43 (s, 2H), 7.06–
7.11 (m, 6H), and 7.56 (d, J = 8.2 Hz, 2H); 13C NMR
(50 MHz, CDCl3, d): 20.89, 21.25, 26.02, 38.50, 55.72,
55.82, 58.50, 110.74, 111.17, 125.86 (2C), 126.93 (2C),
128.61 (2C), 128.76 (2C), 129.11 (2C), 137.22, 137.94,
138.50, 142.74, 147.75, and 148.07; EI-MS [m/z (%)]: 437
(M+, 11), 346 (51), 281 (98), 280 (100), 266 (32), 191 (34),
165 (29), 91 (71), and 65 (23). Elemental analysis: Found C,
68.99; H, 6.25; N, 3.28; C25H27NO4S requires C, 68.62; H,
6.22; N, 3.20. 6,7-Dimethoxy-1-(2-methoxyphenyl)-2-(tolu-
ene-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline. Mp: 95.1–
96.2 ꢁC; IR (KBr, cmÀ1): 2935, 2835, 1598, 1517, 1462,
1330, 1228, 1159, 1031, 975, and 657; 1H NMR (200 MHz,
CDCl3, d): 2.34 (s, 3H), 2.55–2.65 (m, 1H), 2.74–2.91 (m,
1H), 3.34–3.49 (m, 1H), 3.68 (s, 3H), 3.70 (s, 3H), 3.71–3.81
(m, 1H), 3.83 (s, 3H), 6.41 (s, 1H), 6.48 (s, 2H), 6.76–6.83
(m, 3H), 7.10 (d, J = 8.2 Hz, 2H), 7.17–7.26 (m, 1H), and
7.53 (d, J = 8.2 Hz, 2H); 13C NMR (50 MHz, CDCl3, d):
21.25, 26.81, 39.41, 53.41, 54.90, 55.70 (2C), 110.25, 110.57,
110.95, 119.75, 126.02, 126.92 (2C), 127.35, 128.85 (2C),
129.47, 129.91, 130.47, 138.10, 142.34, 147.43, 147.84, and
156.95; EI-MS [m/z (%)]: 453 (M+, 10), 346 (37), 298 (100),
282 (73), 268 (41), 191 (36), 165 (52), 91 (94), and 65 (26).
Elemental analysis: Found C, 66.48; H, 6.13; N, 3.27;
C25H27NO5S requires C, 66.20; H, 6.00; N, 3.09. 6,7-
Dimethoxy-2-(toluene-4-sulfonyl)-1-(2-trifluoromethyl-phen-
yl)-1,2,3,4-tetrahydroisoquinoline. Mp: 106.2–107.0 ꢁC;
IR (KBr, cmÀ1): 2935, 2854, 1612, 1517, 1454, 1348,
1247, 1161, 1037, 916, 817, 715, and 657; 1H NMR
(200 MHz, CDCl3, d): 2.34 (s, 3H), 2.64–2.70 (m, 2H),
3.43–3.61 (m, 2H), 3.66 (s, 3H), 3.79 (s, 3H), 6.35 (s, 1H),
6.44 (s, 2H), 7.13 (d, J = 8.2 Hz, 2H), 7.17–7.37 (m, 3H),
7.56 (d, J = 8.2 Hz, 2H), and 7.69–7.74 (m, 1H); 13C NMR
(50 MHz, CDCl3, d): 21.26, 26.78, 40.71, 54.84, 55.66,
55.73, 110.66, 111.08, 125.91, 126.36, 126.70, 127.32 (2C),
127.51, 128.13, 128.77, 129.13 (2C), 131.03, 131.64, 136.68,
141.22, 142.97, 147.80, and 148.10; EI-MS [m/z (%)]: 491
(M+, 2), 346 (30), 335 (57), 266 (43), 191 (23), 176 (17), 165
(36), 91 (100), 65 (32), and 44 (63). Elemental analysis:
Found C, 60.97; H, 4.95; N, 2.73; C25H24F3NO4S requires
C, 61.09; H, 4.92; N, 2.85. 6,7-Dimethoxy-2-(toluene-4-
sulfonyl)-1-(2-bromophenyl)-1,2,3,4-tetra-hydroisoquino-
line. Mp: 59.2–60.3 ꢁC; IR (KBr, cmÀ1): 2951, 2934, 2834,
1611, 1516, 1464, 1348, 1250, 1162, 1025, 915, 815, 710, and
´
´
2. Beke, G.; Szabo, L. F.; Podanyi, B. J. Nat. Prod. 2002, 65,
649.
3. Larghi, E. L. L.; Amongero, M.; Bracca, A. B. J.;
Kaufman, T. S. Arkivoc 2005, xii, 98.
4. (a) Jackes, B.; Deeks, R. H. L.; Shah, P. K. J. J. Chem.
Soc. (D) 1969, 1283; (b) Singh, K.; Deb, P. K. Tetra-
hedron Lett. 2000, 41, 4977; (c) Bringmann, G.; Ewers, C.
L. J.; Walter, R. Use of Carbonyl Derivatives for Hetero-
cyclic Synthesis. In Comprehensive Organic Synthesis;
Winterfeldt, E., Ed.; Pergamon Press: Oxford, UK, 1991;
Vol. 6, pp 736–740; (d) Leonard, M. S.; Hauze, D. B.;
Carroll, P. J.; Joullie, M. M. Tetrahedron 2003, 59, 6933;
´
(e) Gonzalez, J. F.; de la Cuesta, E.; Avendano, C.
˜
Tetrahedron Lett. 2003, 44, 4395; (f) Kang, I.-J.; Wang,
H.-M.; Su, C.-H.; Chen, L. C. Heterocycles 2002, 57, 1; (g)
Kohno, H.; Yamada, K. Heterocycles 1999, 51, 103; (h)
Lee, S. S.; Kim, S. H.; Yoon, H. S.; Lee, C.-H. Bull.
Korean Chem. Soc. 2003, 24, 1041; (i) Kubo, A.; Saito, N.;
Kawakami, N.; Matsuyama, Y.; Miwa, T. Synthesis 1987,
824; (j) Cheung, G. K.; Earle, M. J.; Fairhurst, R. A.;
Heaney, H.; Shihaibar, K. F.; Eyley, S. C.; Ince, F. Synlett
1991, 721; (k) Kohno, H.; Sekine, Y. Heterocycles 1996,
42, 141; (l) Silveira, C. C.; Bernardi, C. R.; Braga, A. L.;
Kaufman, T. S. Tetrahedron Lett. 1999, 40, 4969; (m)
Silveira, C. C.; Bernardi, C. R.; Braga, A. L.; Kaufman, T.
S. Tetrahedron Lett. 2001, 42, 8947.
5. (a) Comins, D. L.; Badawi, M. M. Tetrahedron Lett. 1991,
32, 2995; (b) MacLean, D. B.; Cundasawmy, N. E. Can. J.
Chem. 1972, 50, 3028; (c) Nagata, H.; Miyazawa, N.;
Ogasawara, K. Chem. Commun. 2001, 1094; (d) Bianchi,
D. A.; Cipulli, M. A.; Kaufman, T. S. Eur. J. Org. Chem.
2003, 4731.
6. Ito, K.; Tanaka, H. Chem. Pharm. Bull. 1977, 25, 1732.
7. Silveira, C. C.; Bernardi, C. R.; Braga, A. L.; Kaufman, T.
S. Tetrahedron Lett. 2003, 44, 6137.
1
657; H NMR (200 MHz, CDCl3, d): 2.35 (s, 3H), 2.76 (t,
J = 6.0 Hz, 2H), 3.44–3.65 (m, 2H), 3.70 (s, 3H), 3.80 (s,
3H), 6.38 (s, 1H), 6.48 (s, 1H), 6.51 (s, 1H), 7.02–7.10 (m,
3H), 7.14 (d, J = 8.4 Hz, 2H), 7.56 (d, J = 8.4 Hz, 1H), and
7.68 (d, J = 8.4 Hz, 2H); 13C NMR (50 MHz, CDCl3, d):
21.35, 27.26, 41.00, 55.75 (2C), 58.18, 110.10, 111.05,
123.72, 125.47, 126.81, 127.35, 127.47 (2C), 128.77, 129.14
(2C), 130.50, 133.15, 136.36, 142.30, 143.00, 147.84,
and 148.10; EI-MS [m/z (%)]: 501 (M+, 4), 346 (80), 266
(93), 191 (39), 176 (29), 165 (75), 91 (100), and 65 (33).
8. Bailey, P. D. J. Chem. Res. 1987, 202.
9. Typical procedure: To a solution of b-phenethylamine
(20–30 mg) in CH2Cl2 or ClCH2CH2Cl (1 mL) cooled to
À20 ꢁC under an argon atmosphere were successively